Eli Lilly slips, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
The News Flicker
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
The Eli Lilly and Novo Nordisk logos. The market share of India's most popular weightloss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmake…
Originally published by CNBC. Read the full article →
More from India
Indian Army Chief visiting Nepal
Kathmandu, August 6: Indian Army Chief General Dhiraj Seth is scheduled to arrive in Nepal on August 16 for a five-day official visit. He will visit Nepal at the invitation of Chief of the Army Staff General Ashok Raj Sigdel. During the visit, President Ramch…
The News Flicker·August 6, 2026
India's big billion-dollar trade deals are done. Now comes the real test
India has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the battle. The bigger challenge now is helping Indian businesses turn preferential market access into exports, investments…
The News Flicker·August 6, 2026
Employment anxiety: India needs jobs that offer a decent living wage and social security
The country's employment statistics show new jobs being created, but many were in agriculture—a reversal of the shift away from farms any emerging economy sees. Meanwhile, euphoria over India’s rapid economic growth has stoked aspirations.
The News Flicker·August 6, 2026